DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Zaleplon is a drug marketed by Aurobindo Pharma, Cipla Ltd, Hikma, Hikma Pharms, Mylan, Orchid Hlthcare, Teva Pharms, Unichem, and Upsher Smith Labs. and is included in ten NDAs.
The generic ingredient in ZALEPLON is zaleplon. There are twelve drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the zaleplon profile page.
A generic version of ZALEPLON was approved as zaleplon by AUROBINDO PHARMA on June 6th, 2008.
Summary for ZALEPLON
|Finished Product Suppliers / Packagers:||10|
|Raw Ingredient (Bulk) Api Vendors:||73|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for ZALEPLON|
|What excipients (inactive ingredients) are in ZALEPLON?||ZALEPLON excipients list|
|DailyMed Link:||ZALEPLON at DailyMed|
Recent Clinical Trials for ZALEPLON
Identify potential brand extensions & 505(b)(2) entrants
|Saint-Joseph University||Phase 3|
|Chang Gung Memorial Hospital||Phase 2/Phase 3|
|Taipei City Hospital||Phase 2/Phase 3|